Clinical Trial Update: Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism

View source ↗

Summary

This clinical trial update investigates regulation of VDR, CaSR, cyclin D1, Ki67, and PCNA in primary hyperparathyroidism, with the study status listed as unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Primary Hyperparathyroidism (PHPT) | Status: UNKNOWN